Genome editing of the HIV co-receptors CCR5 and CXCR4 by CRISPR-Cas9 protects CD4+ T cells from HIV-1 infection

Genome editing of the HIV co-receptors CCR5 and CXCR4 by CRISPR-Cas9 protects CD4+ T cells from HIV-1 infection

Abstract Background The main approach to treat HIV-1 infection is combination antiretroviral therapy (cART). Although cART is effective in reducing HIV-1 viral load and controlling disease progression, it has many side effects, and is expensive for HIV-1 infected patients who must remain on lifetime...

Full description

Bibliographic Details
Main Authors: Zhepeng Liu, Shuliang Chen, Xu Jin, Qiankun Wang, Kongxiang Yang, Chenlin Li, Qiaoqiao Xiao, Panpan Hou, Shuai Liu, Shaoshuai Wu, Wei Hou, Yong Xiong, Chunyan Kong, Xixian Zhao, Li Wu, Chunmei Li, Guihong Sun, Deyin Guo
Format: Article
Language:English
Published: BMC 2017-09-01
Series:Cell & Bioscience
Subjects:
CRISPR-Cas9
CCR5 and CXCR4 simultaneous
HIV-1
AIDS
Online Access:http://link.springer.com/article/10.1186/s13578-017-0174-2

Internet

http://link.springer.com/article/10.1186/s13578-017-0174-2

Similar Items